CNU Continucare Corp.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Continucare Corporation (“Continucare” or the “Company”) (NYSE: CNU) concerning the proposed acquisition of the Company by Metropolitan Health Networks, Inc. (“Metropolitan”) (NYSE AMEX: MDF). Under the terms of the transaction, Continucare’s shareholders would receive $6.25 per share in cash. Shareholders would also receive 0.0414 of a share of Metropolitan common stock for each share they own, presently valued at approximately $0.19.

The investigation is focused on the potential unfairness of the consideration to Continucare shareholders, the process by which the Company’s Board of Directors considered the transaction, and potential conflicts of interests among Continucare Board members.

If you are interested in discussing your rights as a Continucare shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com.

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Continuecare (NYSE:CNU)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024

Continuecare (NYSE:CNU)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024